Biochemical Pharmacology · 2024 · 14 citations · 31 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCancer Stem Cell BiologyCancer Stem CellsOncogenic Signaling PathwaysSignal Transduction In CancerTherapeutic ResistanceCellular ProliferationErk SignalingExtracellular Signal-regulated Kinase PathwayMek InhibitionMek InhibitorsMitogen-activated Protein Kinase SignalingOncogenic TransformationRaf-mek-erk Signaling
The mitogen-activated protein kinase (MAPK/ERK) pathway is pivotal in controlling the proliferation and survival of melanoma cells. Several mutations, including those in BRAF, exhibit an oncogenic effect leading to increased cellular proliferation. As a result, the combination therapy of a MEK inhibitor with a BRAF inhibitor demonstrated higher efficacy and lower toxicity than BRAF inhibitor alone. This combination has become the preferred standard of care for tumors driven by BRAF mutations. Aldehyde dehydrogenase 1A1 (ALDH1A1) is a known marker of stemness involved in drug resistance in several type of tumors, including melanoma. This study demonstrates that melanoma cells overexpressing ALDH1A1 displayed resistance to vemurafenib and trametinib through the activation of PI3K/AKT signaling instead of MAPK axis. Inhibition of PI3K/AKT signaling partially rescued sensitivity to the drugs. Consistently, pharmacological inhibition of ALDH1A1 activity downregulated the activation of AKT and partially recovered responsiveness to vemurafenib and trametinib. We propose ALDH1A1 as a new potential target for treating melanoma resistant to MAPK/ERK inhibitors.
31
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells
MB Kastan, E Schlaffer, JE Russo et al. · Blood · 1990 · 302 citations · Full text
Valerio Ciccone, Erika Terzuoli, Sandra Donnini et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 149 citations · Full text
Medicine, Cancer Biology, Oncology +16